The Beauty Health Company
SKIN
$1.29
-$0.015-1.15%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -19.11% | -22.88% | -5.65% | -1.34% | 9.71% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -19.11% | -22.88% | -5.65% | -1.34% | 9.71% |
| Cost of Revenue | -65.30% | 0.10% | 2.70% | 61.60% | 300.91% |
| Gross Profit | 423.82% | -39.68% | -10.61% | -31.29% | -120.46% |
| SG&A Expenses | -9.83% | -20.79% | -9.46% | -9.62% | 6.55% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -44.12% | -13.72% | -5.01% | 14.52% | 92.73% |
| Operating Income | 73.79% | -68.20% | 1.84% | -650.00% | -1,786.08% |
| Income Before Tax | 76.77% | -112.89% | 94.41% | -252.30% | -7,698.12% |
| Income Tax Expenses | -44.01% | 83.90% | 82.00% | 179.87% | 523.75% |
| Earnings from Continuing Operations | 75.22% | -94.00% | 96.65% | -243.93% | -91,033.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 75.22% | -94.00% | 96.65% | -243.93% | -91,033.33% |
| EBIT | 73.79% | -68.20% | 1.84% | -650.00% | -1,786.08% |
| EBITDA | 83.86% | -391.21% | 24.53% | -335.06% | -4,776.03% |
| EPS Basic | 73.47% | -93.68% | 96.41% | -254.55% | -111,000.00% |
| Normalized Basic EPS | 76.74% | -1,703.64% | 93.98% | -263.60% | -9,462.16% |
| EPS Diluted | 73.21% | -502.37% | 37.78% | -3,547.62% | -1,844.44% |
| Normalized Diluted EPS | 76.74% | -1,496.36% | 94.86% | -263.60% | -9,462.16% |
| Average Basic Shares Outstanding | -6.65% | -6.78% | -7.02% | -6.86% | -11.87% |
| Average Diluted Shares Outstanding | -6.65% | 6.94% | 9.10% | -6.86% | -12.23% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
